We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+3.69%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$14.1B
AUM Growth
-$90M
Cap. Flow
-$394M
Cap. Flow %
-2.79%
Top 10 Hldgs %
21.48%
Holding
1,980
New
111
Increased
767
Reduced
962
Closed
123

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$17.3M
2
AAPL icon
Apple
AAPL
+$12.5M
3
LVS icon
Las Vegas Sands
LVS
+$10.1M
4
XOM icon
ExxonMobil
XOM
+$9.07M
5
ADP icon
Automatic Data Processing
ADP
+$7.98M

Sector Composition

Rank Sector Weight
1 Technology 28.17%
2 Healthcare 8.93%
3 Consumer Discretionary 8.08%
4 Financials 7.53%
5 Communication Services 7.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGZ icon
976
iShares Agency Bond ETF
AGZ
$565M
$1.33M 0.01%
12,348
+1,177
+11% +$126K
BPMC
977
DELISTED
Blueprint Medicines
BPMC
$1.33M 0.01%
12,298
-4,695
-28% -$470K
FBIN icon
978
Fortune Brands Innovations
FBIN
$6.06B
$1.33M 0.01%
20,404
-11,907
-37% -$860K
UGI icon
979
UGI
UGI
$7.33B
$1.32M 0.01%
57,699
+12,257
+27% +$297K
PKX icon
980
POSCO
PKX
$17.5B
$1.32M 0.01%
20,077
-1,532
-7% -$109K
ALE
981
DELISTED
Allete
ALE
$1.32M 0.01%
21,127
+5,880
+39% +$362K
DUOL icon
982
Duolingo
DUOL
$6.12B
$1.32M 0.01%
+6,302
New +$1.29M
BBWI icon
983
Bath & Body Works
BBWI
$4.1B
$1.31M 0.01%
33,496
-5,975
-15% -$274K
LH icon
984
Labcorp
LH
$25.9B
$1.31M 0.01%
6,413
-1,632
-20% -$332K
MCN
985
Madison Covered Call & Equity Strategy Fund
MCN
$118M
$1.3M 0.01%
171,090
+48,966
+40% +$352K
ETRN
986
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$1.3M 0.01%
99,994
-38,538
-28% -$517K
UL icon
987
Unilever
UL
$136B
$1.3M 0.01%
20,956
+14
+0.1% +$827
WMS icon
988
Advanced Drainage Systems
WMS
$11B
$1.29M 0.01%
8,051
-11,557
-59% -$1.93M
APLS
989
DELISTED
Apellis Pharmaceuticals
APLS
$1.29M 0.01%
33,613
+111
+0.3% +$5.03K
IBOC icon
990
International Bancshares
IBOC
$4.57B
$1.28M 0.01%
22,451
-9,118
-29% -$513K
RMD icon
991
ResMed
RMD
$30.7B
$1.28M 0.01%
6,704
-2,456
-27% -$498K
SFNC icon
992
Simmons First National
SFNC
$3.39B
$1.28M 0.01%
72,809
-25,618
-26% -$452K
K
993
DELISTED
Kellanova
K
$1.27M 0.01%
22,104
-12,730
-37% -$751K
CRNX icon
994
Crinetics Pharmaceuticals
CRNX
$8.92B
$1.27M 0.01%
28,449
+24,031
+544% +$1.11M
INSW icon
995
International Seaways
INSW
$4.57B
$1.27M 0.01%
21,540
-519
-2% -$30.2K
GL icon
996
Globe Life
GL
$14.3B
$1.27M 0.01%
15,409
-1,522
-9% -$126K
RUSHA icon
997
Rush Enterprises Class A
RUSHA
$6.22B
$1.27M 0.01%
30,215
-1,136
-4% -$52.2K
OLN icon
998
Olin
OLN
$2.12B
$1.27M 0.01%
26,831
-1,010
-4% -$54K
TEVA icon
999
Teva Pharmaceuticals
TEVA
$41.2B
$1.26M 0.01%
77,658
+44,415
+134% +$684K
BBIO icon
1000
BridgeBio Pharma
BBIO
$16.5B
$1.26M 0.01%
49,576
-760
-2% -$20.8K

Similar funds

Guggenheim Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Guggenheim Capital held 1,980 positions worth $14.1B, down 0.63% from $14.2B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Guggenheim Capital's Q2 2024 filing shows 111 new, 767 increased, 962 reduced and 123 closed positions. Its largest new stake was Arm: 48,961 shares worth $8.01M. The largest sale was VanEck Gold Miners ETF, an estimated $46.2M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Guggenheim Capital's largest Q2 2024 buy was Arm: 48,961 shares worth $8.01M.
  • Guggenheim Capital added most to Microsoft in Q2 2024, an estimated $17.3M increase.
  • Guggenheim Capital's biggest Q2 2024 reduction was Invesco QQQ Trust, cutting an estimated $19.6M.
  • Guggenheim Capital fully exited VanEck Gold Miners ETF in Q2 2024, selling an estimated $46.2M.
  • Guggenheim Capital's ten largest holdings make up 21% of its $14.1B portfolio in Q2 2024.
  • Guggenheim Capital opened 111 new positions and closed 123 in Q2 2024.
  • Guggenheim Capital's portfolio value fell 0.63% quarter-over-quarter to $14.1B.

Based on Guggenheim Capital's 13F filing for Q2 2024, filed 14 Aug 2024.